Wikidata

(Q61957094)

English

An Open-Label Immunogenicity and Pharmacokinetics Study of Daclizumab High Yield Process Prefilled Syringe in Relapsing Remitting Multiple Sclerosis

clinical trial

In more languages

Statements

short name
OBSERVE (English)
0 references
title
A Multicenter, Single-Arm, Open-Label Study to Evaluate the Immunogenicity and Pharmacokinetics of BIIB019, Daclizumab High Yield Process (DAC HYP), Prefilled Syringe Administered by Subcutaneous Injection in Subjects With Relapsing-Remitting Multiple Sclerosis (English)
0 references
medical condition
sclerosis
0 references
multiple sclerosis
0 references
country
Czech Republic
0 references
Hungary
0 references
Poland
0 references
start time
November 2011
0 references
end time
January 2016
0 references
number of participants
133
0 references
research intervention
(E)-phytonadione
0 references
midazolam
0 references
caffeine
0 references
dextromethorphan
0 references
daclizumab
0 references
minimum age
18 year
0 references
maximum age
65 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61957094&oldid=1856981484"